• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MXC
Click for more information
2.38% 2.1¢

MGC PHARMACEUTICALS LTD

Market Cap $57.29M  ! watchlist Created with Sketch. Add to my watchlist

MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on... MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on developing and commercialising phytocannabinoid derived medicines. The Company’s product offering currently targets two widespread medical conditions – epilepsy and dementia. Based in Europe, MGC Pharma is working to meet the growing demand for affordable high-quality phytocannabinoid medicines globally.More

FIJI KAVA NOW STOCKING KAVA TEA ON AMAZON

Health and wellness company Fiji Kava (FIJ) has launched three products from its tea range on Amazon USA. The tea range is the first product to market and aligns with the company’s overall strategy of focussing on the US market and drinking formats.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MXC
Ann: March 2022 Quarterly Activity and Cash Flow Reports 		18/05/22 26 7.6K
18/05/22 Last post  Footmax Comments Created with Sketch.  26  Views Created with Sketch.  7.6K 
MXC
Ann: Response to ASX Aware Query 		18/05/22 2 851
18/05/22 Last post  kurt64 Comments Created with Sketch.  2  Views Created with Sketch.  851 
MXC
Ann: s708A(5)(e) Cleansing Notice 		13/05/22 0 250
13/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  250 
MXC
Ann: Application for quotation of securities - MXC 		13/05/22 0 233
13/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  233 
MXC
Outlook for MXC
3 4 5
13/05/22 259 116K
13/05/22 Last post  StockObserver Comments Created with Sketch.  259  Views Created with Sketch.  116K 
MXC
News: MXC MGC Pharmaceuticals Says Patent Granted For Cannepil Snedds 		10/05/22 0 147
10/05/22 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  147 
MXC
Ann: Patent Granted for CannEpiL SNEDDS 		10/05/22 0 359
10/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  359 
MXC
Ann: Change of Director's Interest Notice x 2 		09/05/22 1 480
09/05/22 Last post  amb005 Comments Created with Sketch.  1  Views Created with Sketch.  480 

See All Discussions arrow Created with Sketch.

Timeline

Response to ASX Aware Query
18 May 09:07
 
s708A(5)(e) Cleansing Notice
13 May 19:03
 
Application for quotation of securities - MXC
13 May 19:01
 
Patent Granted for CannEpiL SNEDDS
10 May 16:41
 
Change of Director's Interest Notice x 2
09 May 08:23
 
March 2022 Quarterly Activity and Cash Flow Reports
29 Apr 18:31
 
View More arrow Created with Sketch.
(20min delay)
Trade with IG Advertisement
Last
2.1¢ 		Change
-0.001(2.38%) 		Mkt cap ! $57.29M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $2.466K 119.0K

Buyers (Bids)

No. Vol. Price($)
36 4573577 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1645024 6
View Market Depth
Last trade - 10.43am 26/05/2022 (20 minute delay) ?
(live)
Last
2.1¢ 		  Change
-0.001 ( 4.55 %)
Open High Low Volume
2.0¢ 2.1¢ 2.0¢ 77619
Last updated 10.43am 26/05/2022 (live) ?
MXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.